Method for hla-dp typing
CA 2098947 A1 · Owner: Bugawan, Teodorica L. · Inventors: Bugawan, Teodorica L.; Erlich, Henry A.; Begovich, Ann B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract, A process for determining an individual's HLA DP genotype from a nucleic acid containing sample obtained from the individual which process, comprises: (a) amplifying a target region of the nucleic acids in the sample under conditions suitable for carrying out a polymerase chain reaction whereby the target region contains a polymorphic region (variable segment) of an HLA DP gene using a specific primer; (b) mixing the amplified nucleic acids with a panel of sequence specific oligonuclcotide (SSO) probes wherein, each probe is complementary to a variant sequence of a variable segment of an HLA DP gene, under conditions wherein SSO probes bind to said amplified nucleic acids to form …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 22, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 22, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 22, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.